adenovirus vector E2b-deleted H1N1 influenza vaccine (E.C7 cell line) (Etubics/Duke Human Vaccine Institute)

N/A

Report date: 2025/01/26 15:48:33

Base Information

Drug Nameadenovirus vector E2b-deleted H1N1 influenza vaccine (E.C7 cell line) (Etubics/Duke Human Vaccine Institute)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEtubics Corp
China Registration ClassN/A

Develop Information

Active CompaniesDuke UniversityEtubics Corp
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A